triazoles has been researched along with ro13-9904 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castanheira, M; Jones, RN; Woosley, LN | 1 |
| Biedenbach, DJ; Castanheira, M; Jones, RN | 1 |
| Chong, Y; Lee, H; Lee, K | 1 |
| de Vries, HJC; Schim-van der Loeff, MF | 1 |
| Avery, A; Bradshaw, CS; Chen, MY; Das, AF; Donovan, B; Fairley, CK; Hardy, D; Hocking, JS; Howden, BP; McNulty, A; Nenninger, A; Oldach, D; Tabrizi, SN; Whiley, D | 1 |
| Craft, JC; Fernandes, P | 1 |
| Aguado, JM; Andrés, A; Caravaca-Fontán, F; Fernández-Ruiz, M; Gutiérrez, E; López-Medrano, F; Morales, E; Praga, M; Sevillano, Á; Trujillo, H | 1 |
| Cerboni, G; Corsica, G; De Luca, F; Docquier, JD; Galleni, M; Gavara, L; Hadjadj, M; Hernandez, JF; Legru, A; Licznar-Fajardo, P; Nauton, L; Sandra Mercuri, P; Sannio, F; Sevaille, L; Verdirosa, F; Vo Hoang, Y | 1 |
2 review(s) available for triazoles and ro13-9904
| Article | Year |
|---|---|
New treatment options for infections caused by increasingly antimicrobial-resistant Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Azithromycin; Barbiturates; Ceftriaxone; Drug Resistance, Bacterial; Drug Therapy, Combination; Gonorrhea; Humans; Isoxazoles; Macrolides; Morpholines; Neisseria gonorrhoeae; Neisseriaceae Infections; Oxazolidinones; Pharyngitis; Spectinomycin; Spiro Compounds; Triazoles | 2016 |
Invasive pulmonary aspergillosis associated with COVID-19 in a kidney transplant recipient.
Topics: Acute Kidney Injury; Administration, Inhalation; Amphotericin B; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antifungal Agents; Azithromycin; Ceftriaxone; COVID-19; Deprescriptions; Female; Glucocorticoids; Graft Rejection; Humans; Hydroxychloroquine; Hyperoxaluria, Primary; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Kidney Failure, Chronic; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Nitriles; Oxygen Inhalation Therapy; Prednisone; Pyridines; Renal Dialysis; SARS-CoV-2; Sputum; Tacrolimus; Tomography, X-Ray Computed; Triazoles | 2021 |
1 trial(s) available for triazoles and ro13-9904
| Article | Year |
|---|---|
Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Australia; Azithromycin; Ceftriaxone; Female; Gonorrhea; Humans; Injections, Intramuscular; Macrolides; Male; Neisseria gonorrhoeae; Treatment Outcome; Triazoles; United States | 2019 |
5 other study(ies) available for triazoles and ro13-9904
| Article | Year |
|---|---|
CEM-101 activity against Gram-positive organisms.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Clarithromycin; Drug Resistance, Bacterial; Drug Synergism; Erythromycin; Gentamicins; Gram-Positive Bacteria; Ketolides; Macrolides; Microbial Sensitivity Tests; Ofloxacin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2010 |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
Topics: Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Ciprofloxacin; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Minocycline; Neisseria meningitidis; Penicillins; Rifampin; Sulfamethoxazole; Triazoles; Trimethoprim | 2010 |
Solithromycin for the treatment of drug-resistant gonorrhoea.
Topics: Azithromycin; Ceftriaxone; Genitalia; Gonorrhea; Humans; Macrolides; Triazoles | 2019 |
Phase 3 trial of treating gonorrhoea with solithromycin.
Topics: Azithromycin; Ceftriaxone; Genitalia; Gonorrhea; Humans; Macrolides; Triazoles | 2019 |
1,2,4-Triazole-3-thione analogues with an arylakyl group at position 4 as metallo-β-lactamase inhibitors.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Ceftriaxone; Ethylenes; HeLa Cells; Humans; Ligands; Meropenem; Microbial Sensitivity Tests; Thiones; Triazoles; Zinc | 2022 |